February 2024, Vol 312, No 7982
Top news stories
People harmed by valproate could receive £100,000 payout, patient safety commissioner says
Pilots to provide PrEP via pharmacies only ‘possible future opportunities’, report warns
Features
‘A mammoth undertaking’: opening the doors to Pharmacy First
Special report: has the online pharmacy bubble burst?
Changing the culture of fluoroquinolone prescribing
Everything you need to know about nitazenes
Opinion
PJ view: Private COVID-19 vaccines should be welcomed with caution
Are we self-actualising in pharmacy?
Early days of Pharmacy First highlight three things we should study
Developing a new model for cross-sector foundation training
Paul Rees: ‘Pharmacy First could be the saviour of general practice’
How credentialing assessors assure patient-focused pharmacy practice
Three core values of community pharmacy are fundamental to a healthy future
Learning & CPD
Perioperative management of type 2 diabetes mellitus
Principles of diagnostic reasoning
How pharmacists can contribute to effective antimicrobial reviews
Lithium monitoring and toxicity management
How to talk to patients about starting antidepressants
The effect of sea kelp on thyroid function in hypothyroidism
How to diagnose and manage Trichomonas vaginalis
Your RPS
RPS consults on advanced curricula for critical care and mental health pharmacy
RPS warns four out of five community pharmacy clinical lead roles could disappear when NHS funding ends
Differential attainment gap persists for black pharmacy students and trainees, says RPS report
